Areef Ishani
Minneapolis VA Health Care System, Minneapolis, MN · US Department of Veterans Affairs · Minneapolis VAMC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Areef Ishani as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:51 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05931276 · CSP #2026 - Beta Blocker Dialyzability on Cardiovascular OutcomesVA Office of Research and Development · recruiting · End-Stage Kidney Disease, End-Stage Renal Disease · study chair
- Ph3NCT02185417 · Diuretic Comparison ProjectVA Office of Research and Development · completed · Hypertension · study chair
- Ph3NCT01446029 · Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)Minneapolis Veterans Affairs Medical Center · completed · Chronic Kidney Disease · principal investigator
- N/ANCT00569556 · Effect of Care Management on Diabetes OutcomesMinneapolis Veterans Affairs Medical Center · completed · Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- CSP #2026A, Beta Blocker Dialyzability on Cardiovascular Outcomes (BRAVO)026A · VA · VETERANS HEALTH ADMINISTRATION · fiscal years 2022Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:51 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.J Bone Miner Res · 2007215 citationsRCR 6.6
- 214 citationsRCR 5.9
- 119 citationsRCR 10.0
- The effect of raloxifene treatment in postmenopausal women with CKD.J Am Soc Nephrol · 2008105 citationsRCR 3.3
- 100 citationsRCR 2.5
- Telehealth by an Interprofessional Team in Patients With CKD: A Randomized Controlled Trial.Am J Kidney Dis · 201686 citationsRCR 3.5
- Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.Am Heart J · 200861 citationsRCR 2.1
- 53 citationsRCR 2.8
- Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis.Kidney Int · 201149 citationsRCR 1.6
- Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes: a randomized controlled trial.Diabetes Care · 201141 citationsRCR 1.7